array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(28) "THE UNIVERSITY OF MANCHESTER"
["slug"]=>
string(37) "b4b93-gb-the-university-of-manchester"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/98d8ad23-27ed-45ad-9295-58212e5366bb"
["description"]=>
string(708) "The Creative Manchester research platform brings together and advances multi-disciplinary and impact-oriented research, supporting and developing research which utilises creative methods and practices, as well as building resources for researchers and students across The University of Manchester.
As a subject, Creativity is a broad church in which many people and organisations reside. This is why we have three distinct research themes that invite people into conversation with us: Creative Industries and Innovation; Creativity, Health and Wellbeing; and Creative and Civic Futures; as well as our Social Responsibility work with local and international communities on creative and cultural initiatives."
["address_street"]=>
string(11) "Oxford Road"
["address_place"]=>
string(10) "MANCHESTER"
["address_region"]=>
NULL
["founding_date"]=>
string(10) "1992-01-01"
["website_domain"]=>
string(16) "manchester.ac.uk"
["website_url"]=>
string(28) "https://www.manchester.ac.uk"
["industry_codes"]=>
array(2) {
[0]=>
string(48) "Colleges, Universities, and Professional Schools"
[1]=>
string(59) "Commercial Economic, Sociological, and Educational Research"
}
["employee_count"]=>
int(10491)
["article_count"]=>
int(479)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(50) "Nanoco is in its strongest ever financial position"
["snippet_en"]=>
string(127) "The University of Manchester spin-out said it was on the brink of commercial production after winning a legal case with Samsung"
["url"]=>
string(84) "https://businesscloud.co.uk/news/nanoco-is-in-its-strongest-ever-financial-position/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/81571229-a224-4096-bb63-69050e02cf8c"
["source"]=>
string(19) "businesscloud.co.uk"
["publication_date"]=>
string(10) "2023-08-08"
["categories"]=>
array(2) {
[0]=>
string(5) "Legal"
[1]=>
string(8) "spin-off"
}
}
[1]=>
array(7) {
["title_en"]=>
string(80) "Solicitors accused of “mistrust and indifference” to lawtech - Legal Futures"
["snippet_en"]=>
string(137) "Solicitors have been described as displaying “mistrust and indifference” to new technology, in a major study of attitudes to lawtech."
["url"]=>
string(101) "https://www.legalfutures.co.uk/latest-news/solicitors-accused-of-mistrust-and-indifference-to-lawtech"
["image_url"]=>
NULL
["source"]=>
string(18) "legalfutures.co.uk"
["publication_date"]=>
string(10) "2023-06-27"
["categories"]=>
array(1) {
[0]=>
string(5) "Legal"
}
}
[2]=>
array(7) {
["title_en"]=>
string(120) "Over a third of people from minority groups have experienced racist assaults, Manchester survey finds - About Manchester"
["snippet_en"]=>
string(260) "More than a third of people from ethnic and religious minority groups in Britain have experienced some form of racist assault, according to new research led by experts from The University of Manchester, the University of St Andrews and King’s College London."
["url"]=>
string(131) "https://aboutmanchester.co.uk/over-a-third-of-people-from-minority-groups-have-experienced-racist-assaults-manchester-survey-finds/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/bbd0f476-21f6-43f9-87c9-2379a5966270"
["source"]=>
string(21) "aboutmanchester.co.uk"
["publication_date"]=>
string(10) "2023-04-20"
["categories"]=>
array(2) {
[0]=>
string(5) "Legal"
[1]=>
string(17) "Academic Research"
}
}
[3]=>
array(7) {
["title_en"]=>
string(7) "Find us"
["snippet_en"]=>
string(302) "More than a third of people from ethnic and religious minority groups in Britain have experienced some form of racist assault, according to new research led by experts from The University of Manchester, the University of St Andrews and King’ s College London.The Evidence for Equality National Survey"
["url"]=>
string(72) "https://www.manchester.ac.uk/discover/news/racist-assaults-survey-finds/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/85f7660b-c0b7-4650-a177-39e44365d8cc"
["source"]=>
string(16) "manchester.ac.uk"
["publication_date"]=>
string(10) "2023-04-19"
["categories"]=>
array(2) {
[0]=>
string(5) "Legal"
[1]=>
string(17) "Academic Research"
}
}
[4]=>
array(7) {
["title_en"]=>
string(102) "Nanoco warns settlement in its IP lawsuit will be at 'lower end of expectations' | TheBusinessDesk.com"
["snippet_en"]=>
string(52) "Shares in Manchester tech firm fall in early trading"
["url"]=>
string(133) "https://www.thebusinessdesk.com/northwest/news/2108352-nanoco-warns-settlement-in-its-ip-lawsuit-will-be-at-lower-end-of-expectations"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/b972325b-5a6d-4075-a825-3d88ce32f536"
["source"]=>
string(19) "thebusinessdesk.com"
["publication_date"]=>
string(10) "2023-01-09"
["categories"]=>
array(2) {
[0]=>
string(5) "Legal"
[1]=>
string(16) "Case Settlements"
}
}
[5]=>
array(7) {
["title_en"]=>
string(68) "Precision medicine trial opens for rare adult and paediatric cancers"
["snippet_en"]=>
string(298) "Cancer Research UK, The University of Manchester and Roche Products Ltd(‘ Roche’), today( Wednesday 23rd), announce that they have opened a multi-drug, precision medicine trial for people with rare cancers who need more treatment options.The trial is set up to recruit both paediatric and adult"
["url"]=>
string(111) "https://www.manchester.ac.uk/discover/news/precision-medicine-trial-opens-for-rare-adult-and-paedatric-cancers/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/e4e9d8da-d6e4-4f6b-a220-6f0e2c4c0307"
["source"]=>
string(16) "manchester.ac.uk"
["publication_date"]=>
string(10) "2022-11-23"
["categories"]=>
array(1) {
[0]=>
string(5) "Legal"
}
}
[6]=>
array(7) {
["title_en"]=>
string(64) "Abbott reports positive data from FreeStyle Libre 2 system trial"
["snippet_en"]=>
string(118) "Abbott has reported positive data from a randomised clinical trial of its FreeStyle Libre 2 glucose monitoring system."
["url"]=>
string(75) "https://www.medicaldevice-network.com/news/abbott-freestyle-libre-2-system/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/3bf85516-94f9-46b2-b7aa-6b1a8878b5a0"
["source"]=>
string(25) "medicaldevice-network.com"
["publication_date"]=>
string(10) "2022-10-07"
["categories"]=>
array(5) {
[0]=>
string(16) "Customer Privacy"
[1]=>
string(5) "R & D"
[2]=>
string(10) "Cybercrime"
[3]=>
string(13) "Data Security"
[4]=>
string(5) "Legal"
}
}
[7]=>
array(7) {
["title_en"]=>
string(65) "University of Manchester leads digital psychosis monitoring trial"
["snippet_en"]=>
string(139) "The University of Manchester is trialling an app that collects data from patients who have had psychosis and uses it to predict a relapse."
["url"]=>
string(104) "https://www.digitalhealth.net/2022/07/university-of-manchester-leads-digital-psychosis-monitoring-trial/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/b1b2b4af-a9fc-4c27-a751-a50d34bdec73"
["source"]=>
string(17) "digitalhealth.net"
["publication_date"]=>
string(10) "2022-07-01"
["categories"]=>
array(4) {
[0]=>
string(5) "Legal"
[1]=>
string(16) "Customer Privacy"
[2]=>
string(5) "R & D"
[3]=>
string(13) "Data Security"
}
}
[8]=>
array(7) {
["title_en"]=>
string(120) "Pharmacogenetics to Avoid Loss of Hearing (PALOH) trial: a protocol for a prospective observational implementation trial"
["snippet_en"]=>
string(249) "Introduction In conjunction with a beta-lactam, aminoglycosides are the first-choice antibiotic for empirical treatment of sepsis in the neonatal period. The m.1555A> G variant predisposes to ototoxicity after aminoglycoside administration and has a"
["url"]=>
string(44) "https://bmjopen.bmj.com/content/11/6/e044457"
["image_url"]=>
NULL
["source"]=>
string(7) "bmj.com"
["publication_date"]=>
string(10) "2021-06-01"
["categories"]=>
array(1) {
[0]=>
string(5) "Legal"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(67)
}
[1]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(53)
}
[2]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(40)
}
[3]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(39)
}
[4]=>
array(2) {
["name"]=>
string(19) "Green & Responsible"
["count"]=>
int(27)
}
[5]=>
array(2) {
["name"]=>
string(17) "Energy Management"
["count"]=>
int(17)
}
[6]=>
array(2) {
["name"]=>
string(13) "Data Security"
["count"]=>
int(12)
}
[7]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(12)
}
[8]=>
array(2) {
["name"]=>
string(13) "GHG Emissions"
["count"]=>
int(11)
}
[9]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(10)
}
[10]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(10)
}
[11]=>
array(2) {
["name"]=>
string(10) "Cybercrime"
["count"]=>
int(10)
}
[12]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(10)
}
[13]=>
array(2) {
["name"]=>
string(7) "Funding"
["count"]=>
int(10)
}
[14]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(9)
}
[15]=>
array(2) {
["name"]=>
string(37) "Product Design & Lifecycle Management"
["count"]=>
int(8)
}
[16]=>
array(2) {
["name"]=>
string(7) "Opening"
["count"]=>
int(7)
}
[17]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(7)
}
[18]=>
array(2) {
["name"]=>
string(6) "Strike"
["count"]=>
int(7)
}
[19]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(7)
}
[20]=>
array(2) {
["name"]=>
string(31) "Water and Wastewater Management"
["count"]=>
int(7)
}
[21]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(7)
}
[22]=>
array(2) {
["name"]=>
string(18) "Ecological Impacts"
["count"]=>
int(7)
}
[23]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(6)
}
[24]=>
array(2) {
["name"]=>
string(22) "Sustainable Investment"
["count"]=>
int(6)
}
[25]=>
array(2) {
["name"]=>
string(11) "Sponsorship"
["count"]=>
int(6)
}
[26]=>
array(2) {
["name"]=>
string(20) "Business Development"
["count"]=>
int(6)
}
[27]=>
array(2) {
["name"]=>
string(27) "Business Model & Innovation"
["count"]=>
int(6)
}
[28]=>
array(2) {
["name"]=>
string(34) "Physical Impacts of Climate Change"
["count"]=>
int(6)
}
[29]=>
array(2) {
["name"]=>
string(19) "Government Policies"
["count"]=>
int(6)
}
}
}
b4b93-gb-the-university-of-manchester
THE UNIVERSITY OF MANCHESTER
Location
Founded
1992-01-01
Website
https://www.manchester.ac.uk
Articles
479 Articles
Category
Colleges, Universities, and Professional Schools
Commercial Economic, Sociological, and Educational Research
Description
The Creative Manchester research platform brings together and advances multi-disciplinary and impact-oriented research, supporting and developing research which utilises creative methods and practices, as well as building resources for researchers and students across The University of Manchester.
As a subject, Creativity is a broad church in which many people and organisations reside. This is why we have three distinct research themes that invite people into conversation with us: Creative Industries and Innovation; Creativity, Health and Wellbeing; and Creative and Civic Futures; as well as our Social Responsibility work with local and international communities on creative and cultural initiatives.
More than a third of people from ethnic and religious minority groups in Britain have experienced some form of racist assault, according to new research led by experts from The University of Manchester, the University of St Andrews and King’s College London.
More than a third of people from ethnic and religious minority groups in Britain have experienced some form of racist assault, according to new research led by experts from The University of Manchester, the University of St Andrews and King’ s College London.The Evidence for Equality National Survey
Cancer Research UK, The University of Manchester and Roche Products Ltd(‘ Roche’), today( Wednesday 23rd), announce that they have opened a multi-drug, precision medicine trial for people with rare cancers who need more treatment options.The trial is set up to recruit both paediatric and adult
Introduction In conjunction with a beta-lactam, aminoglycosides are the first-choice antibiotic for empirical treatment of sepsis in the neonatal period. The m.1555A> G variant predisposes to ototoxicity after aminoglycoside administration and has a
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
